ENTITY
Shenzhen HepaLink Pharmaceutical (H)

Shenzhen HepaLink Pharmaceutical (H) (9989 HK)

80
Analysis
Health Care • China
Shenzhen Hepalink Pharmaceutical Group Co., Ltd researches, produces and sells heparin pharmaceuticals products. The Company's products include heparin sodium active pharmaceutical ingredient.
more
•23 Nov 2025 16:20

A/H Premium Tracker (Week to 21 Nov 2025):Ā  Hs Sharply Underperform As. Year-End Unwinding?

Hs underperformed As in the pairs reasonably sharply. Defensive stocks saw Hs outperform somewhat. Looks like the tide is turning here. Lots of new...

Logo
395 Views
Share
•16 Nov 2025 12:30

A/H Premium Tracker (Week to 14 Nov 2025):Ā  Beautiful Skew Still Behaving Badly, SOE Pair Hs Better

Hs outperformed As slightly as HK shares outperformed mainland shares. Sectors were mixed. There was no beautiful skew as the widest spreads...

Logo
327 Views
Share
•07 Sep 2025 10:15

A-H Premium Weekly (Sep 5th): China Zheshang Bank, China Communications Construction, Goldwind

We analyzed A-H premium changes in the past week and highlight A-H premium changes for China Zheshang Bank, China Communications Construction,...

Logo
631 Views
Share
•27 Jul 2025 10:15

A-H Premium Weekly (Jul 25th): Jiangxi Copper, Dongfang Electric, China Life

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Jiangxi Copper, Dongfang Electric, China Life, China Energy...

Logo
502 Views
Share
•20 Jul 2025 10:15

A-H Premium Weekly (Jul 18th): Livzon Pharmaceutical, Cosco Shipping Development, Beigene

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Livzon Pharmaceutical, Cosco Shipping Development, Beigene,...

Logo
359 Views
Share
x